We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a ...

Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

Shanghai's RiboX Therapeutics begins first-ever circular RNA clinical trial, targeting dry mouth in cancer patients. Company ...

Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...

KLP Kapitalforvaltning AS purchased a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...

Scientists at Oak Ridge National Laboratory have developed the first-ever method of detecting ribonucleic acid, or RNA, ...

Avidity Biosciences (RNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

AIR-001 is designed to restore functional alpha-1 antitrypsin (M-AAT) protein production by precisely repairing the SERPINA1 mutation (PiZ) to address the underlying cause of both lung and liver ...

Binding of miR-3036-5p to CYP18A1 can be prevented by an A-to-I RNA editing, thus elevating CYP18A1 expression, decreasing 20E titer, and finally regulating the wing dimorphism of offspring in aphid.

AIRNA’s lead candidate AIR-001 works by correcting the most common pathologic mutation driving the rare disease alpha-1 ...

Unlike animals, plants do not possess an adaptive immune system with antibodies or T cells to fight viral infections. Instead ...